Marchex Bets on AI as Earnings Pivot

Marchex ((MCHX)) has held its Q1 earnings call. Read on for the main highlights of the call.

Marchex’s latest earnings call carried a cautiously optimistic tone as management framed the quarter as a strategic inflection point toward AI-driven solutions. While acknowledging modest revenue slippage and execution risks, executives leaned heavily on improving profitability, early customer uptake of new AI offerings, and potential upside from the pending Archenia acquisition.

Strategic AI Inflection Point

Marchex signaled a clear shift from being primarily an analytics provider to offering bundled AI-powered solutions that blend insights, automated actions and verifiable outcomes. Management argued this evolution positions the company as an AI beneficiary, leveraging its first-party conversation data and deep vertical expertise to create more defensible, higher-value offerings.

Initial Product Adoption with Archenia Capabilities

The company highlighted early traction from AI-verified outcomes and conversational AI agents co-developed with Archenia. Marchex has pitched the new products to about one-third of its top 100 customers, and roughly half of that group have already signed up for recurring deals or paid pilots, giving management confidence in significant upsell potential.

Q1 Revenue and Near-Term Guidance

First-quarter 2026 revenue came in at $10.6 million, slightly below the prior quarter’s $10.8 million as the company absorbed migration-related impacts. Even so, management guided to sequential revenue growth in the second quarter and further acceleration into the third, targeting roughly 10% run-rate revenue growth from 2025 year-end levels for full-year 2026.

Improved Adjusted EBITDA Guidance

Profitability guidance stepped higher, with second-quarter adjusted EBITDA now expected between $1.6 million and $1.8 million, up from prior indications of more than $1 million. Management also sees standalone third-quarter adjusted EBITDA around $2 million and suggests that, if Archenia closes by then, combined results could approach $2.5 million on an annualized run rate of about $10 million.

Combined Revenue Run-Rate and Growth Opportunity

Assuming the Archenia deal is completed, Marchex outlined a potential combined revenue run rate of roughly $15 million per quarter, or about $60 million annually. Executives believe this platform could support 15% to 20% growth in 2026 and ultimately expand the addressable market toward a $100 million annual revenue opportunity as AI solutions scale across customers.

Operational Efficiency and OpEx Improvements

Management underscored the benefits of organizational realignment and completing major platform initiatives in 2025, which together lowered the recurring cost base. They expect operating expenses to be more than 5% lower than first-quarter levels in the second quarter, supporting improved EBITDA and setting up greater operating leverage as revenue grows.

Margin and Rule of 30–40 Trajectory

The company aims to push adjusted EBITDA margins to at least 10% in 2026 as AI offerings and efficiency gains take hold. If Marchex also achieves its targeted revenue growth, management believes the combined business could approach a “Rule of 30 to 40” profile, a benchmark often used by investors to gauge the balance between growth and profitability.

Balance Sheet and Capital Flexibility

Despite a modest cash decline, Marchex emphasized its asset-light model with low capital expenditure needs and tax attributes that support cash generation. With an existing $3 million share repurchase authorization in place, management suggested improving cash flows could give room for buybacks or other capital returns, while still funding growth.

Sequential Revenue Decline in Q1

The modest 1.9% sequential revenue decline from the fourth quarter reflected some near-term friction as the company migrated customers from legacy systems to the Marchex Engage platform. Management noted that these actions temporarily weighed on revenue entering 2026, but argued they are necessary to enable future growth and simplify the product stack.

Cash Reduction and One-Time Costs

Cash fell to $9.0 million from $9.9 million at the end of 2025, a decline management attributed largely to annual payroll outlays and severance tied to restructuring moves. These one-time costs are expected to yield ongoing savings, and executives indicated they do not anticipate similar levels of cash draw for these items going forward.

Revenue Offset from Platform Migration

The migration to Marchex Engage brought short-term pain, as the company acknowledged that revenue run rates were pressured by the transition. Some of the new sales and upsell wins in the first quarter were effectively offset by the impact of moving customers off legacy platforms, though management expects this drag to fade over time.

Concentration Risk in Customer Base

Marchex’s reliance on its top 100 customers, which account for about 90% of revenue, remains a key risk highlighted on the call. While early AI product adoption from roughly 16% of that group is encouraging, the company must still drive broader penetration across the base to reduce concentration risk and fully realize its AI growth ambitions.

Transaction-Related and Execution Risks

The Archenia acquisition, which underpins much of the combined growth narrative, still faces closing conditions and requires shareholder approval from a specified group. Management acknowledged that integration challenges and execution missteps could jeopardize projected revenue, margins and cross-sell benefits, making disciplined implementation critical.

Ongoing Industry and Execution Uncertainty

Executives also cautioned that the broader industry backdrop is evolving rapidly, adding uncertainty around adoption of AI-based customer engagement tools. The company’s projections depend on successful product sell-through, scaling of sales efforts and continued cost discipline, any of which could fall short and pressure growth or margins.

Forward-Looking Guidance and Outlook

Looking ahead, Marchex guided to steady quarterly revenue increases through 2026, with second-quarter revenue expected to rise from the first quarter and third-quarter growth accelerating further. Management also projects higher adjusted EBITDA in coming quarters, sees the combined company potentially reaching $60 million in annualized revenue and 15% to 20% growth, and aims for margins above 10% as AI solutions gain traction.

Marchex’s earnings call painted the picture of a company trading short-term disruption for longer-term AI-driven upside, with improved profitability guidance helping to offset near-term revenue noise. Investors will now watch whether the Archenia deal closes on schedule and whether management can broaden AI adoption beyond early wins, reduce customer concentration and deliver on its promised growth and margin trajectory.